Service Overview
Organoids are innovative microscopic 3D structures derived from stem cells. providing a robust self-organizing in vitro model. Organoids can be developed from healthy as well as diseased tissue, including cancer lesions, faithfully maintain the morphological, genomical, and pathophysiological characteristics of their corresponding in vivo tumors. They also demonstrate comparable pharmacological profiles and treatment response. It additionally offers the flexibility to scale up for creating patient-relevant models and facilitating high-throughput screening.
We offer a range of services for establishing diverse organoids, encompassing human-derived organoids, patient-derived organoids, mouse-derived organoids, and porcine-derived organoids.
Service Process
Case Report
Organoids Cultured with MasterAim® Medium
Contact Us
By checking the I agree box below and submitting your information,you are agreeing to our privacy policy and you are consenting AimingMed to process your data and to communicate with you according to that policy. Click the Privacy Policy link to read more.
Hangzhou AimingMed Technologies Co., Ltd.
